Skip to content

Updates and Current Landscape for Study Population Selection and Additional Mitigation Strategies in Bioequivalence Studies



    Presenters

    Karen Li, PharmD
    Pharmacologist
    DTPII | ORS | OGD | CDER | FDA

    Duyen Nguyen, PharmD
    Pharmacologist
    DTPII | ORS | OGD | CDER | FDA

    Leave a Comment

    Your email address will not be published. Required fields are marked *